CompletedNCT02793050

Retrospective Study of Trabectedin in Soft Tissue Sarcomas

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Italian Sarcoma Group
Principal Investigator
Stefano Ferrari, MD
Italian Sarcoma Group
Intervention
Trabectedin(drug)
Enrollment
510 target
Eligibility
18 years · All sexes
Timeline
20162018

Study locations (26)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02793050 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma

← Back to all trials